miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma

Cell Death and Disease

Volumn 7, Issue 3, 2016, Pages

  Liu, Y ^a   Zhao, R ^a   Wang, H ^a   Luo, Y ^a   Wang, X ^a   Niu, W ^a   Zhou, Y ^a   Wen, Q ^b   Fan, S ^b   Li, X ^a   Xiong, W ^a   Ma, J ^a   Tan, M ^c   Li, G ^a   Zhou, M ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODOMAIN CONTAINING 7; MICRORNA 141; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; BRD7 PROTEIN, HUMAN; MICRORNA; MIRN141 MICRORNA, HUMAN; NONHISTONE PROTEIN; PTEN PROTEIN, HUMAN; RNA;

5-8F CELL LINE; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COMPARATIVE STUDY; DOWN REGULATION; ECTOPIC EXPRESSION; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; HEK293 CELL LINE; HNE-1 CELL LINE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; SURVIVAL RATE; TUMOR GROWTH; TUMOR XENOGRAFT; CELL TRANSFORMATION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADULT; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; HEK293 CELLS; HUMANS; MALE; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA, NEOPLASM; SIGNAL TRANSDUCTION;

EID: 85004154073     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.64     Document Type: Article

References (60)

1. Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol 2015; 33: 3356–3364.
2. Pan JJ, Ng WT, Zong JF, Chan LL, O'Sullivan B, Lin SJ et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 2015; 122: 546–558.
3. Xu Y, Cao W, Zhou M, Li C, Luo Y, Wang H et al. Inactivation of BRD7 results in impaired cognitive behavior and reduced synaptic plasticity of the medial prefrontal cortex. Behav Brain Res 2015; 286: 1–10.
4. Zhou M, Liu H, Xu X, Zhou H, Li X, Peng C et al. Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression. J Cell Biochem 2006; 98: 920–930.
5. Peng C, Zhou J, Liu HY, Zhou M, Wang LL, Zhang QH et al. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. J Cell Biochem 2006; 97: 882–892.
6. Tae S, Karkhanis V, Velasco K, Yaneva M, Erdjument-Bromage H, Tempst P et al. Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes. Nucleic Acids Res 2011; 39: 5424–5438.
7. Mantovani F, Drost J, Voorhoeve PM, Del Sal G, Agami R. Gene regulation and tumor suppression by the bromodomain-containing protein BRD7. Cell Cycle 2010; 9: 2777–2781.
8. Harte MT, O'Brien GJ, Ryan NM, Gorski JJ, Savage KI, Crawford NT et al. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer Res 2010; 70: 2538–2547.
9. Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H et al. BRD7 is a candidate tumour suppressor gene required for p53 function. Nat Cell Biol 2010; 12: 380–389.
10. Burrows AE, Smogorzewska A, Elledge SJ. Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc Natl Acad Sci USA 2010; 107: 14280–14285.
11. Balasubramanian A, Subramaniam R, Narayanan V, Annamalai T, Ramanathan A. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas. Asian Pac J Cancer Prev 2015; 16: 1615–1619.
12. Park YA, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH et al. Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma. Clin Cancer Res 2014; 20: 565–575.
13. Liu H, Zhang L, Niu Z, Zhou M, Peng C, Li X et al. Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells. BMC Cancer 2008; 8: 253.
14. Xue Z, Zhao J, Niu L, An G, Guo Y, Ni L. Up-regulation of miR-300 promotes proliferation and invasion of osteosarcoma by targeting BRD7. PLoS One 2015; 10: e0127682.
15. Zhou M, Xu XJ, Zhou HD, Liu HY, He JJ, Li XL et al. BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis. Mol Cell Biochem 2006; 292: 205–212.
16. Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG et al. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. J Cell Physiol 2004; 200: 89–98.
17. Peng C, Liu HY, Zhou M, Zhang LM, Li XL, Shen SR et al. BRD7 suppresses the growth of nasopharyngeal carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways. Mol Cell Biochem 2007; 303: 141–149.
18. Chiu YH, Lee JY, Cantley LC. BRD7, a tumor suppressor, interacts with p85alpha and regulates PI3K activity. Mol Cell 2014; 54: 193–202.
19. Wilczynska A, Bushell M. The complexity of miRNA-mediated repression. Cell Death Differ 2015; 22: 22–33.
20. Wang Y, Liu C, Luo M, Zhang Z, Gong J, Li J et al. Chemotherapy-induced miRNA-29c/ Catenin-delta signaling suppresses metastasis in gastric cancer. Cancer Res 2015; 75: 1332–1344.
21. Wang GG, Konze KD, Tao J. Polycomb genes, miRNA, and their deregulation in B-cell malignancies. Blood 2015; 125: 1217–1225.
22. Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong RM, Miller KM et al. Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development. Cancer Discov 2015; 6: 188–201.
23. Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu X et al. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Clin Cancer Res 2014; 20: 2617–2630.
24. Zhao G, Wang B, Liu Y, Zhang JG, Deng SC, Qin Q et al. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Mol Cancer Ther 2013; 12: 2569–2580.
25. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G et al. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 2011; 18: 1628–1639.
26. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894–907.
27. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006; 130: 2113–2129.
28. van Jaarsveld MT, Helleman J, Boersma AW, van Kuijk PF, van Ijcken WF, Despierre E et al. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 2013; 32: 4284–4293.
29. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 2011; 17: 1627–1635.
30. Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J et al. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 2010; 31: 559–566.
31. Liu H, Zhou M, Luo X, Zhang L, Niu Z, Peng C et al. Transcriptional regulation of BRD7 expression by Sp1 and c-Myc. BMC Mol Biol 2008; 9: 111.
32. Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 2015; 15: 321–333.
33. Kaeser MD, Aslanian A, Dong MQ, Yates JR 3rd, Emerson BM. BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem 2008; 283: 32254–32263.
34. Xu K, Xiong W, Zhou M, Wang H, Yang J, Li X et al. Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network. Mol Cell Biochem 2015; 411: 57–71.
35. Lin L, Liang H, Wang Y, Yin X, Hu Y, Huang J et al. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3beta in hepatocellular carcinoma cells. BMC Cancer 2014; 14: 879.
36. Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V et al. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem 2014; 289: 12550–12565.
37. Yang CF, Yang GD, Huang TJ, Li R, Chu QQ, Xu L et al. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/ AKT pathway by a positive feedback loop. Oncogene 2015; e-pub ahead of print 16 November 2015; doi:10.1038/onc.2015.402.
38. Penna E, Orso F, Taverna D. miR-214 as a key hub that controls cancer networks: small player, multiple functions. J Invest Dermatol 2015; 135: 960–969.
39. Chen P, Guo X, Zhou H, Zhang W, Zeng Z, Liao Q et al. SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1. PLoS One 2013; 8: e56929.
40. Zhu B, Tian J, Zhong R, Tian Y, Chen W, Qian J et al. Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population. Mol Carcinog 2015; 54: 761–768.
41. Li D, Yang Y, Zhu G, Liu X, Zhao M, Li X et al. MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer. FEBS Lett 2015; 589: 2218–2223.
42. Yu X, Zhang L, Wen G, Zhao H, Luong LA, Chen Q et al. Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells. Cell Death Differ 2015; 22: 1170–1180.
43. Wade SL, Langer LF, Ward JM, Archer TK. MiRNA-mediated regulation of the SWI/SNF chromatin remodeling complex controls pluripotency and endodermal differentiation in human ESCs. Stem Cells 2015; 33: 2925–2935.
44. Yin M, Ren X, Zhang X, Luo Y, Wang G, Huang K et al. Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-kappaB p65 to evoke reactive oxygen species generation and p53 activation. Oncogene 2015; 34: 691–703.
45. Yu T, Liu L, Li J, Yan M, Lin H, Liu Y et al. MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN. Oncotarget 2015; 6: 30239–30250.
46. Zhao Q, Assimopoulou AN, Klauck SM, Damianakos H, Chinou I, Kretschmer N et al. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells. Oncotarget 2015; 6: 38934.
47. Zhang Y, Chen HX, Zhou SY, Wang SX, Zheng K, Xu DD et al. Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway. Mol Cancer 2015; 14: 56.
48. Park SW, Herrema H, Salazar M, Cakir I, Cabi S, Basibuyuk Sahin F et al. BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K. Cell Metab2014; 20: 73–84.
49. Kzhyshkowska J, Rusch A, Wolf H, Dobner T. Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7. Biochem J 2003; 371: 385–393.
50. Kikuchi M, Okumura F, Tsukiyama T, Watanabe M, Miyajima N, Tanaka J et al. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. Biochim Biophys Acta 2009; 1793: 1828–1836.
51. Sun J, Nie J, Hao B, Li L, Xing G, Wang Z et al. Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes. Cell Signal 2008; 20: 1151–1158.
52. Brozovic A, Duran GE, Wang YC, Francisco EB, Sikic BI. The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells. Mol Oncol 2015; 9: 1678–1693.
53. Tang K, Xu H. Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis. Sci Rep 2015; 5: 10272.
54. Zhou X, Ye F, Yin C, Zhuang Y, Yue G, Zhang G. The interaction between MiR-141 and lncRNA-H19 in regulating cell proliferation and migration in gastric cancer. Cell Physiol Biochem 2015; 36: 1440–1452.
55. Wang SC, Lin XL, Wang HY, Qin YJ, Chen L, Li J et al. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway. Oncotarget 2015; 6: 36713–36730.
56. Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF, Yuan CC et al. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 2015; 34: 2156–2166.
57. Palacios F, Abreu C, Prieto D, Morande P, Ruiz S, Fernandez-Calero T et al. Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation. Leukemia 2015; 29: 115–125.
58. Bian Y, Hall B, Sun ZJ, Molinolo A, Chen W, Gutkind JS et al. Loss of TGF-beta signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 2012; 31: 3322–3332.
59. Dey P, Strom A, Gustafsson JA. Estrogen receptor beta upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer. Oncogene 2014; 33: 4213–4225.
60. Wang W, Wen Q, Xu L, Xie G, Li J, Luo J et al. Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma. PLoS One 2014; 9: e106098.